Cell-free DNA is DNA that is found in the bloodstream. This can be captured as a biological sample such as blood or serum for disease analysis and is suitable for a range of research applications such as real-time PCR, digital PCR and next-generation sequencing.
Scope of the Report:The global Cell Free DNA Isolation and Extraction market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cell Free DNA Isolation and Extraction.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cell Free DNA Isolation and Extraction market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cell Free DNA Isolation and Extraction market by product type and applications/end industries.
Market Segment by Companies, this report covers Agilent Technologies
Berry Genomics
BioCAT
Roche
GATC Biotech
Illumina
Merck
Natera
Norgen Biotek
QIAGEN
SeraCare Life Sciences
Thermo Fisher Scientific
Aline Biosciences
Promega
STRECK
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers Cell Free DNA Extraction and Isolation Kits
Cell Free DNA Automated Instruments
Consumables
Market Segment by Applications, can be divided into Non-Invasive Prenatal Testing
Oncology
Transplant Rejection and Other Disease Condition
Others
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
